Pavitra Kotini

Array ( [id] => 3704571 [patent_doc_number] => 05654174 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Herpes simplex virus glycoprotein D variants' [patent_app_type] => 1 [patent_app_number] => 8/499568 [patent_app_country] => US [patent_app_date] => 1995-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 6430 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654174.pdf [firstpage_image] =>[orig_patent_app_number] => 499568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693873 [patent_doc_number] => 05618694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Human papilloma virus Type 57, a method for preparing expression products thereof' [patent_app_type] => 1 [patent_app_number] => 8/479401 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 797 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618694.pdf [firstpage_image] =>[orig_patent_app_number] => 479401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729548 [patent_doc_number] => 05665535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis' [patent_app_type] => 1 [patent_app_number] => 8/468057 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5541 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665535.pdf [firstpage_image] =>[orig_patent_app_number] => 468057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662849 [patent_doc_number] => 05648459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions' [patent_app_type] => 1 [patent_app_number] => 8/466711 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4851 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648459.pdf [firstpage_image] =>[orig_patent_app_number] => 466711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729521 [patent_doc_number] => 05665533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Skin test to human papillomavirus type 16' [patent_app_type] => 1 [patent_app_number] => 8/408175 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1195 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665533.pdf [firstpage_image] =>[orig_patent_app_number] => 408175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691619 [patent_doc_number] => 05618536 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Chimeric papillomavirus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/319467 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7923 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618536.pdf [firstpage_image] =>[orig_patent_app_number] => 319467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621080 [patent_doc_number] => 05601973 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Seroreactive regions on HPV 16 proteins E1 and E2' [patent_app_type] => 1 [patent_app_number] => 8/237418 [patent_app_country] => US [patent_app_date] => 1994-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6850 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601973.pdf [firstpage_image] =>[orig_patent_app_number] => 237418 [rel_patent_id] =>[rel_patent_doc_number] =>)